Medicine and Dentistry
Cicatricial Alopecia
100%
Disease
50%
Traction Alopecia
42%
Trichorrhexis invaginata
35%
Acral Lentiginous Melanoma
28%
Alopecia Mucinosa
28%
Scalp
24%
Pruritus
22%
Quality of Life
19%
Hair Disease
17%
Uterine Fibroid
17%
Race Difference
16%
Patient Experience
16%
Gene Expression
15%
Atopic Dermatitis
15%
Prurigo nodularis
15%
Self Esteem
14%
Proteomics
14%
Systemic Therapy
14%
Photopheresis
14%
Scar Formation
14%
Maduromycosis
14%
Loose Anagen Hair Syndrome
14%
Genetic Trait
14%
Cellulitis
14%
Lifespan
14%
Clinician
14%
Microbiome
14%
Hyperactivation
14%
Clinical Feature
14%
Tertiary Care
14%
Male Type Alopecia
14%
Dermatological Disease
14%
Minoxidil
14%
Mycosis fungoides
14%
Cyclin-Dependent Kinase 4
14%
Systematic Review
14%
Dissecting Cellulitis of the Scalp
14%
Cyclin-Dependent Kinase 6
14%
Black Skin
14%
Humoral Immunity
14%
Gene Expression Profiling
14%
Thalidomide
14%
Percutaneous Aortic Valve
14%
Nodular Melanoma
10%
Drug Therapy
9%
Topical Corticosteroid
7%
Protein Expression
7%
Frontal Fibrosing Alopecia
7%
Differential Diagnosis
7%
Keyphrases
Central Centrifugal Cicatricial Alopecia
28%
Acral Lentiginous Melanoma
28%
Scalp
21%
Retrospective Review
16%
Patient Experience
16%
Scarring Alopecia
14%
Management Implications
14%
Extracorporeal Photopheresis
14%
Madura Foot
14%
Gordonia Terrae
14%
Traction Alopecia
14%
Genetic Response
14%
Inhibitor Resistance
14%
Limited Disease
14%
Clinical Application
14%
Thalidomide
14%
Loose Anagen Syndrome
14%
Tertiary Care
14%
Gene Expression Profiling
14%
Disease Subtypes
14%
Collaborative Efforts
14%
Gene Expression Profile
14%
Mycosis Fungoides
14%
Uterine Leiomyoma
14%
Hair Breakage
14%
Alopecia Areata
14%
Prurigo Nodularis
14%
Racial Differences
14%
Dissecting Cellulitis
14%
Cyclin-dependent Kinase 4/6 Inhibitors
14%
Hyperactivity
14%
Genetic Characteristics
14%
Systemic Therapy
14%
Scalp Microbiome
14%
Hair Camouflage
10%
Lesional
8%
Dermatological Diseases
5%
Tumor
5%
BRAF V600E mutation
5%
Melanoma Patients
5%
Retrospective Analysis
5%
Melanoma
5%
African American
5%
African American Patients
5%